CWI1-2 is an IGF2BP2 inhibitor that binds IGF2BP2 and inhibits its interaction with m6A-modified target transcripts, induces apoptosis and differentiation, and shows promising anti-leukemic effects[1].
Molecular Weight:
519.77
Purity:
98.18
CAS Number:
[2408590-36-1]
Formula:
C22H17Cl3N6O3
Target:
Apoptosis
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted